Self-amplifying mRNA COVID-19 vaccine shows superiority over conventional mRNA vaccine 01-Oct-2024 By Larissa Warneck-Silvestrin A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger immune response than a conventional mRNA vaccine for up to one year and at a much lower dose.